The current hepatitis C virus prevalence in china may have resulted mainly from an officially encouraged plasma campaign in the 1990s: A coalescence inference with genetic sequences

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12041-12050

  Lu, Ling ^a,b   Tong, Wangxia ^a   Gu, Lin ^a   Li, Chunhua ^b   Lu, Teng ^c   Tee, Kok Keng ^d   Chena, Guihua ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; E1 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHINA; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRAL CONTAMINATION; VIROGENESIS; VIRUS TRANSMISSION; ALGORITHM; BAYES THEOREM; BLOOD; CLASSIFICATION; DNA SEQUENCE; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; PHYLOGENY; POLYMERASE CHAIN REACTION; TRANSMISSION;

HEPATITIS C VIRUS;

ALGORITHMS; BAYES THEOREM; CHINA; EVOLUTION, MOLECULAR; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84886264701     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01773-13     Document Type: Article

References (42)

1. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
2. Pham VH, Nguyen HD, Ho PT, Banh DV, Pham HL, Pham PH, Lu L, Abe K. 2011. Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination. Jpn. J. Infect. Dis. 64:537-539.
3. Zhou X, Chan PK, Tam JS, Tang JW. 2011. A possible geographic origin of endemic hepatitis C virus 6a in Hong Kong: evidences for the association with Vietnamese immigration. PLoS One 6:e24889. doi:10.1371/journal.pone.0024889.
4. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R. 1994. Geographical distribution of hepatitisCvirus genotypes in blood donors: an international collaborative survey. J. Clin. Microbiol. 32:884-892.
5. Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, Syhavong B, Phetsouvanah R, Sheridan I, Humphreys IS, Lu L, Newton PN, Klenerman P. 2009. Genetic history of hepatitis C virus in East Asia. J. Virol. 83:1071-1082.
6. Simmonds P. 2004. Genetic diversity and evolution of hepatitis C virus-15 years on. J. Gen. Virol. 85:3173-3188.
7. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. 2001. The epidemic behavior of the hepatitis C virus. Science 292: 2323-2325.
8. Pybus OG, Cochrane A, Holmes EC, Simmonds P. 2005. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 5:131-139.
9. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. 2002. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc. Natl. Acad. Sci. U. S. A. 99:15584-15589.
10. Goedert JJ, Chen BE, Preiss L, Aledort LM, Rosenberg PS. 2007. Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990. Am. J. Epidemiol. 165:1443-1453.
11. Hauri AM, Armstrong GL, Hutin YJ. 2004. The global burden of disease attributable to contaminated injections given in health care settings. Int. J. STD AIDS 15:7-16.
12. Soetjipto Handajani R, Lusida MI, Darmadi S, Adi P, Soemarto, Ishido S, Katayama Y, Hotta H. 1996. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J. Clin. Microbiol. 34:2875-2880.
13. Drummond A, Pybus OG, Rambaut A. 2003. Inference of viral evolutionary rates from molecular sequences. Adv. Parasitol. 54:331-358.
14. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7:214.
15. Donnelly P, Tavare S. 1995. Coalescents and genealogical structure under neutrality. Annu. Rev. Genet. 29:401-421.
16. Ferraro D, Genovese D, Argentini C, Giordano V, Pizzillo P, Stroffolini T, Craxi A, Rapicetta M, Di Stefano R. 2008. Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: the Camporeale model. J. Med. Virol. 80:1723-1731.
17. Markov PV, Pepin J, Frost E, Deslandes S, Labbe AC, Pybus OG. 2009. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J. Gen. Virol. 90:2086-2096.
18. Nakano T, Lu L, He Y, Fu Y, Robertson BH, Pybus OG. 2006. Population genetic history of hepatitis C virus 1b infection in China. J. Gen. Virol. 87:73-82.
19. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. 2006. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144:705-714.
20. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, McCaughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F. 2011. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 31(Suppl. 2):61-80.
21. Lei XZ, Shigeko N, Deng XW, Wang S, Qin S, Liu L, Tang H, Zhao L, Lei B, Yoshihiro A. 1999. Prevalence of hepatitis C virus infection in the general population and patients with liver disease in China. Hepatol. Res. 14:135-143.
22. Xia GL, Liu CB, Cao HL, Li S, Zhan MY, Sub CA, Nan JH, Qi XQ. 1996. Prevalence of hepatitis B and C virus infections in the general Chinese population: results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int. Hepatol. Commun. 5:62-73.
23. Gu L, Tong W, Yuan M, Lu T, Li C, Lu L. 21 May 2013. An increased diversity ofHCVisolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants. J. Clin. Virol. 57:311-317.
24. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. 2005. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J. Med. Virol. 75:538-549.
25. Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K. 2011. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J. Viral Hepat. 18:42-52.
26. Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, Wang H, Tong W, Rong X, Li G, Yuan M, Li C, Abe K, Lu L, Chen G. 2012. HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One 7:e28006. doi:10.1371/journal.pone.0028006.
27. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. 2005. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin. Infect. Dis. 41(Suppl. 1):S18-S24.
28. Huang CH, Zhou JK, Liu L, Jiang RM, Cao YQ, Mu ZY, Zhang Y. 2009. Investigating genotype of HCV distribution among residents in a "blood donation" village in Hebei Province. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23:8-10.
29. Peng JS, Wang X, Liu MQ, Zhou DJ, Gong J, Xu HM, Chen JP, Zhu HH, Zhou W, Ho WZ. 2008. Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China. Virus Res. 135:191-196.
30. Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren Q, Feng Q, He G. 2011. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS One 6:e16817. doi:10.1371/journal.pone.0016817.
31. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
32. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52:696-704.
33. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. 2003. The epidemiology and iatrogenic transmission of hepatitisCvirus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20:381-387.
34. Yuan MQ, Lu T, Li C, Lu L. 2013. The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions. PLoS One 8:e64698. doi:10.1371/journal.pone.0064698.
35. Ji Y, Ren QH, Zhu ZY, Qu DM, Qiu ZK, Li JF, Mei H, Yan HY. 1998. Investigation and analysis ofHCVinfection in Chinese blood donors. Acta Acad. Med. Sinica 203:240-241.
36. Kaufman J, Jing J. 2002. China and AIDS-the time to act is now. Science 296:2339-2340.
37. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM. 2002. Blood banking in China. Lancet 360:1770-1775.
38. Shi XL, Ren QH, Zhu ZY, Qu DM, Ji Y, Peng DH, Ni SQ. 1999. Hepatitis C virus infection in blood donors in the People's Republic of China. Transfusion 39:913.
39. Gray RR, Parker J, Lemey P, Salemi M, Katzourakis A, Pybus OG. 2011. The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evol. Biol. 11:131.
40. Njouom R, Frost E, Deslandes S, Mamadou-Yaya F, Labbe AC, Pouillot R, Mbélesso P, Mbadingai S, Rousset D, Pépin J. 2009. Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J. Gen. Virol. 90:2452-2456.
41. Pouillot R, Lachenal G, Pybus OG, Rousset D, Njouom R. 2008. Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect. Genet. Evol. 8:676-681.
42. Xia X, Lu L, Tee KK, Zhao W, Wu J, Yu J, Li X, Lin Y, Mukhtar MM, Hagedorn CH, Takebe Y. 2008. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J. Med. Virol. 80:1142-1152.